attachment
attachment

Give detailed answers to above mentioned questions . Reference Harrison book

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
All nine questions have been answered comprehensively. Here is a summary of what was covered:

Summary of Topics Covered

Q31-32 - Cardiomyopathy (General + Primary/Secondary):
  • Definition, morphologic classification (HCM/DCM/RCM/ARVC)
  • Primary vs secondary causes (with full table of systemic diseases)
  • Two-hit genetic model of pathogenesis
  • General diagnostic workup (Harrison's Ch. 266, p. 2045)
Q33 - Hypertrophic Cardiomyopathy:
  • Genetics (1 in 500; sarcomere mutations - MYH7, MYBPC3)
  • Dynamic LVOT obstruction mechanism, SAM, hemodynamics
  • Clinical features (murmur behavior, S4, bifid pulse)
  • Treatment: beta-blockers, verapamil, disopyramide, mavacamten (new FDA-approved myosin inhibitor)
  • Surgical: myectomy vs alcohol septal ablation; ICD for sudden death risk
Q34 - Dilated Cardiomyopathy:
  • Genetic (titin, lamin A/C) and acquired causes
  • Heart failure syndrome presentation + echo/MRI findings
  • Four-pillar GDMT: ARNI, beta-blocker, MRA, SGLT2i
  • ICD, CRT, transplant indications
Q35 - Restrictive Cardiomyopathy:
  • ATTR amyloidosis (tafamidis - FDA-approved), endomyocardial fibrosis, Fabry, sarcoidosis
  • Key distinction from constrictive pericarditis (table)
  • Treatment of underlying disease
Q36-37 - Infective Endocarditis:
  • Vegetation pathology, acute vs subacute, NVE/PVE/CIED-IE
  • Duke-ISCVID 2015 criteria (major/minor, definite/possible/rejected)
  • Antibiotic regimens by organism
  • Surgical indications (HF, uncontrolled infection, embolic risk, abscess)
Q38 - Heart Failure Pathogenesis + Classification:
  • RAAS, SNS, natriuretic peptide axes
  • HFrEF/HFmrEF/HFpEF by EF; ACC/AHA stages A-D; NYHA I-IV
Q39 - Chronic Heart Failure:
  • Detailed symptom complex (LV vs RV failure symptoms)
  • Physical exam findings (S3, JVP, crackles, pulsus alternans)
  • Labs (BNP/NT-proBNP, troponin, iron studies)
  • Instruments (echo, MRI, RHC, CXR with Kerley B lines)
  • GDMT treatment with device therapy and advanced options
This is a shared conversation. Sign in to Orris to start your own chat.